Last reviewed · How we verify
long acting injectable risperidone, Conventional Dose Group
long acting injectable risperidone, Conventional Dose Group is a Small molecule drug developed by Northwestern University. It is currently FDA-approved. Also known as: Risperidone Consta/Conventional Dose.
At a glance
| Generic name | long acting injectable risperidone, Conventional Dose Group |
|---|---|
| Also known as | Risperidone Consta/Conventional Dose |
| Sponsor | Northwestern University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- long acting injectable risperidone, Conventional Dose Group CI brief — competitive landscape report
- long acting injectable risperidone, Conventional Dose Group updates RSS · CI watch RSS
- Northwestern University portfolio CI
Frequently asked questions about long acting injectable risperidone, Conventional Dose Group
What is long acting injectable risperidone, Conventional Dose Group?
long acting injectable risperidone, Conventional Dose Group is a Small molecule drug developed by Northwestern University.
Who makes long acting injectable risperidone, Conventional Dose Group?
long acting injectable risperidone, Conventional Dose Group is developed and marketed by Northwestern University (see full Northwestern University pipeline at /company/northwestern-university).
Is long acting injectable risperidone, Conventional Dose Group also known as anything else?
long acting injectable risperidone, Conventional Dose Group is also known as Risperidone Consta/Conventional Dose.
What development phase is long acting injectable risperidone, Conventional Dose Group in?
long acting injectable risperidone, Conventional Dose Group is FDA-approved (marketed).
Related
- Manufacturer: Northwestern University — full pipeline
- Also known as: Risperidone Consta/Conventional Dose
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing